Publication
Association Between COVID-19 and the Incidence of Type 1 Diabetes in Portugal - a Registry Study
dc.contributor.author | Bjerregaard-Andersen, Morten | |
dc.contributor.author | Da Silva, Jessica | |
dc.contributor.author | Diogo, Rui | |
dc.contributor.author | Claro, Ana Raquel | |
dc.contributor.author | Ferro, Inês | |
dc.contributor.author | Romana, Andreia | |
dc.contributor.author | Rocha, Patrícia | |
dc.contributor.author | Sá, Beatriz | |
dc.contributor.author | Lobarinhas, Goreti | |
dc.contributor.author | Rolim, Sara | |
dc.contributor.author | Juhl, Claus Bogh | |
dc.contributor.author | Højlund, Kurt | |
dc.contributor.author | Fernandes, Isabel | |
dc.contributor.author | Antunes, Sónia | |
dc.contributor.author | Félix Calha, Maria Manuela | |
dc.contributor.author | Gama, Guida | |
dc.contributor.author | Amálio, Sofia | |
dc.contributor.author | Figueiras, Mariana | |
dc.contributor.author | Silva, Teresa | |
dc.contributor.author | Rosado, Margarida | |
dc.contributor.author | Ferrão, Estela | |
dc.contributor.author | Arez, Luísa | |
dc.contributor.author | Baptista, Ana | |
dc.contributor.author | Martins Ferreira, Adriana | |
dc.contributor.author | Alba, Diana | |
dc.contributor.author | Godinho, Carlos | |
dc.contributor.author | Leite, Ana Luísa | |
dc.contributor.author | Lopes, Lurdes | |
dc.contributor.author | Sampaio, Maria Lurdes | |
dc.contributor.author | Serra-Caetano, Joana | |
dc.contributor.author | Carvalho, Eugenia | |
dc.date.accessioned | 2025-04-16T14:43:47Z | |
dc.date.available | 2025-04-16T14:43:47Z | |
dc.date.issued | 2024-08-09 | |
dc.description.abstract | Background: Viral respiratory infections may precipitate type 1 diabetes (T1D). A possible association between the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, and the incidence of T1D is being determined. This study was carried out using Portuguese registries, aiming at examining temporal trends between COVID-19 and T1D. Methods: Hospital data, comparing the incidence before and during the COVID-19 pandemic, from children and young adults diagnosed with new-onset T1D, was acquired beginning in 2017 and until the end of 2022. Data was obtained from nine different Portuguese hospital units. The impact of the COVID-19 pandemic, beginning in March 2020, was assessed comparing the annual numbers of new-onset T1D cases. The annual median levels of glucose, glycated hemoglobin (HbA1c) and fasting C-peptide at T1D diagnosis were compared. The annual number of diabetic ketoacidosis (DKA) episodes among new T1D cases was also assessed at two centers. Results: In total, data from 574 newly diagnosed T1D patients was analyzed, including 530 (92.3%) children. The mean ages for child and adult patients were 9.1 (SD 4.4) and 32.8 (SD 13.6) years, respectively. 57.8% (331/573) were male, one patient had unknown sex. The overall median (25-75 percentiles) levels of glucose, HbA1c and fasting C-peptide at diagnosis were 454 mg/dL (356-568), 11.8% (10.1-13.4) and 0.50 µg/L (0.30-0.79), respectively. DKA at T1D diagnosis was present in 48.4% (76/157). For eight centers with complete 2018 to 2021 data (all calendar months), no overall significant increase in T1D cases was observed during the COVID-19 pandemic, i.e. 90 cases in 2018, 90 cases in 2019, 112 in 2020 and 100 in 2021 (P for trend = 0.36). Two of the centers, Faro (CHUA) and Dona Estefânia (CHULC) hospitals, did however see an increase in T1D from 2019 to 2020. No significant changes in glucose (P = 0.32), HbA1c (P = 0.68), fasting C-peptide (P = 0.20) or DKA frequency (P = 0.68) at the time of T1D diagnosis were observed over the entire study period. Conclusion: The T1D incidence did not increase significantly, when comparing the years before and during the COVID-19 pandemic, nor did key metabolic parameters or number of DKA episodes change. | eng |
dc.identifier.citation | BMC Endocr Disord . 2024 Aug 9;24(1):145. | |
dc.identifier.doi | 10.1186/s12902-024-01667-5 | |
dc.identifier.pmid | 39123199 | |
dc.identifier.uri | http://hdl.handle.net/10400.17/5079 | |
dc.language.iso | eng | |
dc.peerreviewed | yes | |
dc.publisher | BioMed Central | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Adolescent | |
dc.subject | Blood Glucose / analysis | |
dc.subject | Blood Glucose / metabolism | |
dc.subject | COVID-19* / complications | |
dc.subject | COVID-19* / epidemiology | |
dc.subject | Child | |
dc.subject | Diabetes Mellitus | |
dc.subject | Diabetic Ketoacidosis / epidemiology | |
dc.subject | Glycated Hemoglobin / analysis | |
dc.subject | Incidence | |
dc.subject | Portugal / epidemiology | |
dc.subject | Registries* | |
dc.subject | SARS-CoV-2 | |
dc.subject | HDE END PED | |
dc.title | Association Between COVID-19 and the Incidence of Type 1 Diabetes in Portugal - a Registry Study | eng |
dc.type | text | |
dspace.entity.type | Publication | |
oaire.citation.startPage | 145 | |
oaire.citation.title | BMC Endocrine Disorders | |
oaire.citation.volume | 24 | |
oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 |